{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T08:13:42Z","timestamp":1769415222422,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012030","name":"Yakult Honsha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10388-025-01169-w","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:56:00Z","timestamp":1764046560000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trial"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-4661","authenticated-orcid":false,"given":"Chikatoshi","family":"Katada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumu","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako Eguchi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutoshi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasaburo","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"1169_CR1","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med"},{"key":"1169_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","volume":"81","author":"M Stahl","year":"2017","unstructured":"Stahl M, Walz MK, Riera-Knorrenschild J, et al. Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): long-term results of a controlled randomised trial. Eur J Cancer. 2017;81:183\u201390.","journal-title":"Eur J Cancer"},{"key":"1169_CR3","first-page":"1","volume":"32","author":"GA von Dobeln","year":"2018","unstructured":"von Dobeln GA, Klevebro F, Jacobsen AB, et al. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial. Dis Esophagus. 2018;32:1\u201311.","journal-title":"Dis Esophagus"},{"key":"1169_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(24)00745-1","volume":"404","author":"K Kato","year":"2024","unstructured":"Kato K, Machida R, Ito Y, et al. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial. Lancet. 2024;404:55\u201366.","journal-title":"Lancet"},{"key":"1169_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus. 2023;20:343\u201372.","journal-title":"Esophagus"},{"key":"1169_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/cas.12274","volume":"104","author":"H Hara","year":"2013","unstructured":"Hara H, Tahara M, Daiko H, et al. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma. Cancer Sci. 2013;104:1455\u201360.","journal-title":"Cancer Sci"},{"key":"1169_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00280-016-3062-2","volume":"78","author":"H Satake","year":"2016","unstructured":"Satake H, Tahara M, Mochizuki S, et al. A prospective, multicenter phase I\/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma. Cancer Chemother Pharmacol. 2016;78:91\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1169_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/bjc.2016.350","volume":"115","author":"T Yokota","year":"2016","unstructured":"Yokota T, Kato K, Hamamoto Y, et al. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer. Br J Cancer. 2016;115:1328\u201334.","journal-title":"Br J Cancer"},{"key":"1169_CR9","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.ijrobp.2024.06.019","volume":"120","author":"C Katada","year":"2024","unstructured":"Katada C, Yokoyama T, Watanabe A, et al. Optimizing organ-preservation strategies through chemotherapy-based selection in esophageal squamous cell carcinoma: results from the CROC Multi-Institutional Phase 2 Clinical Trial. Int J Radiat Oncol Biol Phys. 2024;120:1353\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1169_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/den.13483","volume":"32","author":"T Kadota","year":"2020","unstructured":"Kadota T, Abe S, Yoda Y, et al. Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma. Dig Endosc. 2020;32:337\u201345.","journal-title":"Dig Endosc"},{"key":"1169_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10388-024-01043-1","volume":"21","author":"T Yano","year":"2024","unstructured":"Yano T, Hayashi Y, Ishihara R, et al. Remarkable response as a new indicator for endoscopic evaluation of local efficacy of nonsurgical treatments for esophageal cancer. Esophagus. 2024;21:85\u201394.","journal-title":"Esophagus"},{"key":"1169_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10147-011-0278-3","volume":"17","author":"R Ishihara","year":"2012","unstructured":"Ishihara R, Yamamoto S, Iishi H, et al. Predicting the effects of chemoradiotherapy for squamous cell carcinoma of the esophagus by induction chemotherapy response assessed by positron emission tomography: toward PET-response-guided selection of chemoradiotherapy or esophagectomy. Int J Clin Oncol. 2012;17:225\u201332.","journal-title":"Int J Clin Oncol"},{"key":"1169_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11523-017-0540-3","volume":"13","author":"K Harada","year":"2018","unstructured":"Harada K, Wang X, Shimodaira Y, et al. Early metabolic change after induction chemotherapy predicts histologic response and prognosis in patients with esophageal cancer: Secondary analysis of a randomized trial. Target Oncol. 2018;13:99\u2013106.","journal-title":"Target Oncol"},{"key":"1169_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1245\/s10434-020-08738-6","volume":"28","author":"A Sonoda","year":"2021","unstructured":"Sonoda A, Yoshida N, Shiraishi S, et al. Total lesion glycolysis ratio in positron emission tomography\/computed tomography images during neoadjuvant chemotherapy can predict pathological tumor regression grade and prognosis in patients with locally advanced squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2021;28:167\u201374.","journal-title":"Ann Surg Oncol"},{"key":"1169_CR15","volume-title":"Japanese classification of esophageal cancer","author":"The Japan Esophageal Society","year":"2022","unstructured":"The Japan Esophageal Society. Japanese classification of esophageal cancer. 12th ed. Tokyo: Kanehara\u00a0and Co., Ltd; 2022.","edition":"12"},{"key":"1169_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijrobp.2022.07.007","volume":"114","author":"H Takeuchi","year":"2022","unstructured":"Takeuchi H, Ito Y, Machida R, et al. A single-arm confirmatory study of definitive chemoradiation therapy including salvage treatment for clinical stage II\/III esophageal squamous cell carcinoma (JCOG0909 Study). Int J Radiat Oncol Biol Phys. 2022;114:454\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1169_CR17","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","volume":"161","author":"K Kato","year":"2021","unstructured":"Kato K, Ito Y, Nozaki I, et al. Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. Gastroenterology. 2021;161:1878\u201386.","journal-title":"Gastroenterology"}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-025-01169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10388-025-01169-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-025-01169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T21:05:04Z","timestamp":1769375104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10388-025-01169-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1007\/s10388-025-01169-w","relation":{},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"value":"1612-9059","type":"print"},{"value":"1612-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol and subsequent amendments were approved by the Clinical Research Review Board of the Kitasato Institute (N12018005) in accordance with the ethical principles of the Declaration of Helsinki. Signed informed consent was obtained from all patients before registration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Chikatoshi Katada and Wasaburo Koizumi received research funding from Yakult Honsha Co., Ltd. Other authors indicated no potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}